IBS Linked to Elevated Triglyceride Levels in Large-Scale GWAS
A large-scale genome-wide association study involving 2.8 million people has identified a genetic link between irritable bowel syndrome (IBS) and elevated triglyceride levels. The findings suggest that IBS may involve metabolic pathways beyond the traditional gut-brain axis.
Why it matters
This discovery could lead to new, mechanism-based therapies for IBS patients who do not respond to current treatments.
A genome-wide association study (GWAS) among almost 2.8 million individuals has revealed a causal link between irritable bowel syndrome (IBS) and elevated triglyceride levels.
The article reports on scientific research findings using objective, evidence-based language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in